Foams with function: advancing topical drug delivery through formulation innovation

How methodically engineered foam formulations, paired with the right packaging system, solve the stability, dosing and adherence problems that hold traditional creams and ointments back.

Executive summaryTopical therapies are uniquely positioned to deliver targeted treatment with minimal systemic exposure, but translation from lab efficacy to real-world effectiveness is frequently limited by formulation and delivery challenges. Problems such as chemical and physical instability, inconsistent dosing, poor aesthetic properties and difficult application can reduce adherence and impact clinical outcomes. However, when methodically formulated, engineered and packaged, foams and advanced semi-solid dispersions can successfully overcome many of these limitations.

This whitepaper outlines how foam formulations and optimized packaging systems, including a novel Bag-on-Valve (BoV) patented technology and aerosols, can improve stability, dosing uniformity, patient adherence and market differentiation. By reviewing scientific trade-offs — solubilization versus suspension, particle engineering and excipient strategies — topical drug delivery developers can achieve foams with both performance and pleasing sensory attributes. Container–closure systems are equally important, protecting product integrity and enabling precise dispensing throughout the product life cycle.

The right combination of formulation science, process engineering and packaging expertise can transform complex ideas into launch-ready products. By partnering with pharmaceutical sponsors, Formulated Solutions helps mitigate technical risks, accelerate development timelines and deliver differentiated topical therapies that perform in the real world.